Sort
30,917 grants matching “tumor microenvironment”
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
$649,094Cesar M Castro · Massachusetts General Hospital · R01 · FY2022 · CA
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$648,963Richard J Price · University Of Virginia · R01 · FY2021 · EB
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$648,944Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$648,944Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Stomal Senescence Regulator of Tumor Immunity and Progression
$648,846David G Denardo · Washington University · R01 · FY2024 · CA
TME CoBRE Administration Core
$648,741Paul R Lockman · West Virginia University · P20 · FY2022 · GM
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
$648,725Raghu Kalluri · Beth Israel Deaconess Medical Center · U01 · FY2011 · CA
Vaccine and radiation for the therapy of human cancers
$648,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Ecology and Evolution of Breast Carcinogenesis
$648,685Mehdi Damaghi · State University New York Stony Brook · U01 · FY2023 · CA
Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers
$648,677Lauren Elizabeth Colbert · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence
$648,602Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2025 · NS
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$648,555David A. Hafler · Yale University · R01 · FY2024 · CA
Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers
$648,501Hua Li · Washington University · R01 · FY2025 · CA
Tumor microenvironmental biomarkers of breast cancer invasion
$648,428Robert B West · Stanford University · R01 · FY2025 · CA
Defining the role of cytomegalovirus in glioblastoma therapies
$648,427Sean Edward Lawler · Brown University · R01 · FY2023 · CA
Mechanisms Promoting Copper Dependent Cell Death in Cancer
$648,408Peter Tsvetkov · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
$648,382Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2023 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$648,380Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Immunological consequences of LINE-1 expression in cancer
$648,232Katherine B Chiappinelli · George Washington University · R01 · FY2024 · CA
Planning and Evaluation Core
$647,912Jason A Wilder · Northern Arizona University · U54 · FY2023 · CA
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins
$647,843Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma
$647,740Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
$647,718Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U01 · FY2012 · CA
ALL immunobiology and the bone marrow niche
$647,674Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene
$647,645Dan Mercola · University Of California-Irvine · U01 · FY2011 · CA